ANG Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve Pursuant to the Regulation ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
ANG Lifesciences India Ltd has informed BSE that its Board of Directors will meet on Friday, 30th May 2025 at 5:30 PM at the registered office in Amritsar. The main agenda is to consider and approve the Standalone and Consolidated Audited Financial Results for the quarter and financial year ended 31st March 2025. Any other business with the Chairman's permission may also be taken up. The trading window for insiders remains closed until 48 hours after the board meeting concludes.
This is a routine procedural filing under SEBI's listing regulations ahead of the FY25 results announcement. Investors should watch for the upcoming audited results on 30th May 2025 for actual financial performance; the filing itself has no direct impact on the share price.